ATOS
Atossa Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.70 / 10
Outperform
Analyst consensus is a unanimous Strong Buy, yielding an 8.05 weighted rating. Fund‑flow score is 7.35 (good), with positive small, medium and large inflows despite a negative overall trend. Sentiment score 7.7 reinforces bullish expectations.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionAscendiant Capital
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for ATOS?
- ATOS holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.70/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
